| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 390,302 | 334,658 | 370,366 | 451,722 | | Cost of Revenue | 190,136 | 164,713 | 181,144 | 232,373 | | | Gross Profit | 200,166 | 169,945 | 189,222 | 219,349 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 178,342 | 168,598 | 181,369 | 180,534 | | Non Recurring | 2,571 | 3,320 | 4,973 | (282) | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 19,253 | (1,973) | 2,880 | 39,097 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 1 | 4 | (5,111) | 14 | | Earnings Before Interest And Taxes | 19,254 | (1,969) | (2,231) | 39,111 | | Interest Expense | 1,851 | 1,866 | 3,091 | 2,627 | | Income Before Tax | 17,403 | (3,835) | (5,322) | 36,484 | | Income Tax Expense | 5,880 | (1,172) | 281 | 12,811 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 11,523 | (2,663) | (5,603) | 23,673 | | | Non-recurring Events | | Discontinued Operations | (80) | (59) | (159) | 16 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 11,443 | (2,722) | (5,762) | 23,689 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $11,443 | ($2,722) | ($5,762) | $23,689 |
|
0.11% Nasdaq 
0.01%
Income Statement
